DETERMINATION OF PLASMA PROCAINAMIDE AND N-ACETYLPROCAINAMIDE CONCENTRATION BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY.DUTCHER JS; STRONG JM.1977; CLIN. CHEM.; U.S.A.; DA. 1977; VOL. 23; NO 7; PP. 1318-1320; BIBL. 13 REF.Article

EFFECT OF ACTIVE DRUG METABOLITES ON PLASMA LEVEL-RESPONSE CORRELATIONS.ATKINSON AJ JR; STRONG JM.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 2; PP. 95-109; BIBL. 1 P. 1/2Article

DETERMINATION OF THE N-HYDROXY AND PHENOLIC METABOLITES OF DRUGS DERIVED FROM ACETANILIDE BY O-ALKYLATION AND SELECTED ION MONITORING.KAPETANOVIC IM; DUTCHER JS; STRONG JM et al.1977; ANAL. CHEM.; U.S.A.; DA. 1977; VOL. 49; NO 12; PP. 1843-1846; BIBL. 27 REF.Article

SIMULTANEOUS MEASUREMENT OF PLASMA CONCENTRATIONS OF LIDOCAINE AND ITS DESETHYLATED METABOLITE BY MASS FRAGMENTOGRAPHYSTRONG JM; ATKINSON AJ JR.1972; ANAL. CHEM.; U.S.A.; DA. 1972; VOL. 44; NO 14; PP. 2287-2290; BIBL. 15REF.Serial Issue

METABOLIC STRUCTURE-ACTIVITY RELATIONSHIP FOR A HOMOLOGOUS SERIES OF PHENACETIN ANALOGSKAPETANOVIC IM; STRONG JM; MIEYAL JJ et al.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 209; NO 1; PP. 20-24; BIBL. 32 REF.Article

SIMPLE INTERFACE FOR AUTOMATED MASS FRAGMENTOGRAPHY WITH A STANDARD LABORATORY DATA SYSTEMSTRONG JM; ATKINSON AJ JR; FERGUSON RJ et al.1975; ANAL. CHEM.; U.S.A.; DA. 1975; VOL. 47; NO 9; PP. 1720-1721; BIBL. 3 REF.Article

I.V. MISONIDAZOLE (NSC 261037): REPORT OF INITIAL CLINICAL EXPERIENCESCHWADE JG; STRONG JM; GANGJI D et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 1; PP. 33-39; BIBL. 8 REF.Article

THE MOLECULAR COMPONENTS OF NITROFURANTOIN CRITICAL TO ITS INHIBITORY EFFECT UPON PLATELET AGGREGATION. = LES COMPOSANTS MOLECULAIRES DE LA NITROFURANTOINE CRITIQUES POUR SON EFFET INHIBITEUR SUR L'AGREGATION PLAQUETTAIREROSSI EC; MIEYAL JJ; STRONG JM et al.1975; MOLEC. PHARMACOL.; U.S.A.; DA. 1975; VOL. 11; NO 6; PP. 751-758; BIBL. 18 REF.Article

STUDIES ON THE METHYLATION OF DIETHYLSTILBESTROL BY PREPARATIONS OF RAT LIVERSOSSI N; STRONG JM; DINGELL JV et al.1980; PHARMACOLOGY; CHE; DA. 1980; VOL. 20; NO 4; PP. 173-180; BIBL. 11 REF.Article

APPLICATION OF A SIMPLE COMPETITIVE PROTEIN-BINDING ASSAY TECHNIQUE TO THE PHARMACOKINETICS OF N-(PHOSPHONACETYL)-L-ASPARTATE IN HUMANSERLICHMAN C; STRONG JM; CHABNER BA et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 6; PP. 1902-1906; BIBL. 16 REF.Article

PHENYTOIN-MISONIDAZOLE: POSSIBLE METABOLIC INTERACTIONGANGJI D; SCHWADE JG; STRONG JM et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 1; PP. 155-156; BIBL. 12 REF.Article

ANALYSIS OF TISSUE PROGESTERONE RESIDUES BY GAS CHROMATOGRAPHY MASS SPECTRAL AND RADIOIMMUNOLOGICAL DETECTION METHODS.WINKLER VN; STRONG JM; FINLEY RA et al.1977; STEROIDS; U.S.A.; DA. 1977; VOL. 29; NO 6; PP. 739-747; BIBL. 4 REF.Article

IDENTIFICATION OF GLYCINEXYLIDIDE IN PATIENTS TREATED WITH INTRAVENOUS LIDOCAINESTRONG JM; PARKER M; ATKINSON AJ JR et al.1973; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1973; VOL. 14; NO 1; PP. 67-72; BIBL. 15REF.Serial Issue

STUDIES ON THE O-DEMETHYLATION OF MISONIDAZOLE BY RAT LIVER MICROSOMESSHOEMACER DD; MCMANUS ME; HOERAUF R et al.1982; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 6; PP. 1343-1347; BIBL. 16 REF.Article

IN VITRO ACETYLATION OF DRUGS BY HUMAN BLOOD CELLSDRAYER DE; STRONG JM; JONES B et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 6; PP. 499-505; BIBL. 37REF.Article

DETERMINATION OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) IN DOG, SERUM AND URINE BY GAS CHROMATOGRAPHY AND SELECTED ION MONITORINGSTRONG JM; KINNEY YE; BRANFMAN AR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 775-780; BIBL. 6 REF.Article

PHARMACOKINETICS IN MAN OF THE N-ACETYLATED METABOLITE OF PROCAINAMIDE.STRONG JM; DUTCHER JS; WOONG KU LEE et al.1975; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1975; VOL. 3; NO 4; PP. 223-235; BIBL. 20 REF.Article

DOSE-RESPONSE CURVES FOR PREDICTING MISONIDAZOLE-INDUCED PERIPHERAL NEUROPATHYSCHWADE JG; MAKUCH RW; STRONG JM et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 9; PP. 1743-1750; BIBL. 15 REF.Article

MISONIDAZOLE DOSE AND TUMOR LEVEL RELATIONSHIPS: EFFECTS OF INDIVIDUAL VARIATION IN RAT OF MISONIDAZOLE METABOLISM AND ABSORPTION FROM THE GASTROINTESTINAL TRACTSTRONG JM; SCHWADE JG; GANGJI D et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 1; PP. 41-46; BIBL. 8 REF.Article

PLASMA LEVELS OF METHSUXIMIDE AND N-DESMETHYLMETHSUXIMIDE DURING METHSUXIMIDE THERAPY = TAUX PLASMATIQUE DE METHSUXIMIDE ET DE N-DESMETHYLMETHSUXIMIDE AU COURS DE LA THERAPEUTIQUE PAR LE METHSUXIMIDESTRONG JM; ABE T; GIBBS EL et al.1974; NEUROLOGY; U.S.A.; DA. 1974; VOL. 24; NO 3; PP. 250-255; BIBL. 14REF.Article

MISONIDAZOLE BLOOD AND CEREBROSPINAL FLUID KINETICS IN MONKEYS FOLLOWING INTRAVENOUS AND INTRATHECAL ADMINISTRATIONGANGJI D; POPLACK DG; SCHWADE J et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 1; PP. 29-34; BIBL. 14 REF.Article

NONLINEAR PHARMACOKINETICS OF MISONIDAZOLE AND DESMETHYLMISONIDAZOLE IN THE ISOLATED PERFUSED RAT LIVERMCMANUS ME; MONKS A; COLLINS JM et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 219; NO 3; PP. 669-674; BIBL. 25 REF.Article

ABSOLUTE BIOAVAILABILITY IN MAN OF N-ACETYLPROCAINAMIDE DETERMINED BY A NOVEL STABLE ISOTOPE METHOD.STRONG JM; DUTCHER JS; WOONG KU LEE et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 613-622; BIBL. 21 REF.Article

ANTIARRHYTHMIC POTENCY OF N-ACETYLPROCAINAMIDEELSON J; STRONG JM; WOONG KU LEE et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 2; PP. 134-140; BIBL. 13REF.Article

IDENTIFICATION OF SEPARATE ACYL-COA: GLYCINE AND ACYL-COA: L-GLUTAMINE N-ACYLTRANSFERASE ACTIVITIES IN MITOCHONDRIAL FRACTIONS FROM LIVER OF RHESUS MONKEY AND MAN.WEBSTER LT JR; SIDDIQUI UA; LUCAS SV et al.1976; J. BIOL. CHEM.; U.S.A.; DA. 1976; VOL. 251; NO 11; PP. 3352-3358; BIBL. 14 REF.Article